Latest News about IMPL
Recent news which mentions IMPL
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 15, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 20, 2022
From Benzinga
Impel NeuroPharma's Return On Capital Employed Insights
September 09, 2022
Tickers
IMPL
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
From Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
From Benzinga
From Benzinga
Earnings Scheduled For May 16, 2022
May 16, 2022
From Benzinga
Mizuho Remains Bullish On This Small-Cap Stock's Migraine Candidate, But Why Did It Cut Price Target
May 13, 2022
From Benzinga
66 Biggest Movers From Yesterday
May 03, 2022
From Benzinga
From Benzinga
Earnings Scheduled For March 24, 2022
March 24, 2022
From Benzinga
From Benzinga
From Benzinga
Impel Neuro's Trudhesa Nasal Spray Migraine Treatment Performed Better Than Expected In Q4
January 18, 2022
Tickers
IMPL
From Benzinga
41 Stocks Moving In Monday's Mid-Day Session
November 15, 2021
From Benzinga
Earnings Scheduled For November 15, 2021
November 15, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 28, 2021
From Benzinga
60 Biggest Movers From Friday
September 13, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Slides Over 100 Points; Echo Global Logistics Shares Spike Higher
September 10, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 10, 2021
From Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Apellis Pharmaceuticals Shares Plunge
September 10, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.